You are here:  » Home   » Products   » Brainostic  


deutschdeutsch
Flash-Player installieren
ScheBo-MediaBox



» Flash-Player installieren
» Watch video in bigger size

ScheBo® · Biotech AG
Netanyastrasse 3
35394 Giessen
Germany

Phone +49 (0)641 / 4996-0
Fax +49 (0)641 / 4996-77
Email-contact

ScheBo® • Brainostic™

Test for detection of the Specified Risk Material (SRM) of brain and spinal cord in meat products and from swabs


New: GFAP-ELISA Test !

ScheBo® • Biotech AG developed and patented a method to detect high risk material for BSE - brain and spinal cord - in meat products, independent of the species. This procedure is highly specific and sensitive. It allows the detection of central nervous system tissue in all meat products and sausages (raw, cooked or requiring boiling in water), as well as on contaminated surfaces and carcasses. This method is unique because of its sensitive, antibody-based detection of central nervous system tissue even in heat-treated meat products.

  • » Background
    The BSE-Problem

  • » References/literature
    Please find here selected literature - partly as download.

  • » GFAP ELISA Kit
    GFAP-ELISA for the quantitative detection of the Specified Risk Material (SRM) of brain and spinal cord in meat products and from swabs

  • » Laboratory Service
    Our service: send us your samples and we will test them for you (price available on request).


« back


AEO-Certificate
The Main Customs Office of Giessen, Germany issued an AEO-F Certificate (Authorized Economic Operator – Customs Simplifications plus Security and Safety) to ScheBo Biotech AG on September 30, 2011.
read...
Lecture DDW 2011: New molecular markers: M2-PK
Lecture of Prof. Dr. Sybille Mazurek on WEO/OMED Colorectal Cancer Screening Committee Meeting DDW 2011.
read...
Biomarker ′M2-PK′ Identified as Key Enzyme in Cancer Diagnosis and Therapy
Ground Breaking Findings on Understanding Cancer Published in ′Science′
read...
Video: Focus 2010 lecture on M2-PK
The high sensitivity (c.80%) and high specificity (>90%) of the M2-PK stool test for colorectal cancer screening and detection, plus benefits for patients, laboratories and doctors, was presented at Focus 2010
read...
Tumour M2-PK as a stool marker for colorectal cancer
Comparative analysis in a large sample of unselected older adults vs colorectal cancer patients.
read...
Coeliac disease and pancreatic exocrine insufficiency
The data have shown that pancreatic insufficiency, demonstrated by low faecal pancreatic elastase-1 levels, is common in adult coeliac disease patients.
read...
ISO-Certificate
Our ISO-Cerficate as pdf-download.
read...